Director — Jason E. Dodier: The filing discloses the election of a new independent director to fill a vacancy created by a board size increase, which is a routine governance event.

Regulation FD Disclosure. On August 18, 2026, AIxCrypto Holdings, Inc. (the “Company”) issued a press release announcing a strategic shift toward robotics operations and commercialization. The press release announced: (i) the Company’s planned orderly exit from its Digital Asset Treasury strategy and intention to focus resources on robotics operations and commercialization; (ii) the completion by RoboShare, the Company’s online marketplace for robot sharing and rental, of its first paid comme…

Results of Operations and Financial Condition On August 7, 2026, the Company issued a press release announcing its financial and operational results for the three months ended June 30, 2026, and an investor webcast that occurred on August 7, 2026 to discuss such results and update shareholders on general corporate developments. The press release and the investor presentation are attached as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K (this “Form 8-K”) and are inco…

Entry into a Material Definitive Agreement. On July 29, 2026, AIxCrypto Holdings, Inc. (the “Company”), a Delaware corporation, entered into a Consulting Agreement (the “Agreement”) with Aibot US Operation Inc (“Aibot” or the “Consultant”), a Delaware corporation located at 21515 Hawthorne Blvd, Ste 420, Torrance, California 90503. The Agreement is effective as of July 16, 2026 (the “Effective Date”) and continues through July 15, 2027, unless extended by mutual written consent of the parties…

Regulation FD Disclosure. On June 22, 2026, AIxCrypto Holdings, Inc. (the “Company”) issued a press release announcing its debut at Automate 2026, North America’s largest automation and robotics exhibition, held at McCormick Place in Chicago, Illinois. The press release announced: (i) the official launch of RoboShare, a matchmaking platform for on-demand robot rentals; (ii) the introduction of AIXC01, an infrastructure network for autonomous assets built around four core functions—Identity, A…

Neither this Current Report on Form 8-K nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy shares of common stock or other securities of the Company.

Entry into a Material Definitive Agreement. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Purchase Agreement (as defined below). On June 16, 2026, AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”) entered into a common shares purchase agreement (the “Purchase Agreement”) with Gold King Arthur Holding Limited, a Hong Kong limited liability company (the “Purchaser”) pursuant to which the Company agreed to sell and is…

Other Events. Discontinuation of Legacy Biotechnology Business On May 21, 2026, the Board approved the discontinuation and structured wind-down of the Company’s legacy biotechnology business segment. Prior to reaching this determination, the Company’s management evaluated strategic alternatives for the segment, including a potential sale of the business. Based on this evaluation, the Board concluded that an orderly wind-down is in the best interests of the Company and its stockholders. The Co…

Co-Chief Executive Officer, Director, Chief Financial Officer, President — Kevin Richardson II, Koti Meka, Campbell Becher: Multiple senior executives resigned from their positions.

Entry into a Material Definitive Agreement. On May 12, 2026, the AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with CABG ACQUISITION CORP. (“Buyer”), pursuant to which the Company agreed to sell, assign, and transfer to the Buyer, all of the Company’s right, title, and interest in the Note Package (as such term is defined in the Note Purchase Agreement), which includes (a) that certain Amended and Resta…

Results of Operations and Financial Condition On May 11, 2026, the Company issued a press release announcing its financial and operational results for the three months ended March 31, 2026, and an investor webcast that occurred on May 11, 2026 to discuss such results and update shareholders on general corporate developments. The press release and the investor presentation are attached as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K (this “Form 8-K”) and are incorpo…

Entry into a Material Definitive Agreement Amendments of Entrusted Investment Agreement As previously disclosed by AIxCrypto Holdings, Inc., a Delaware corporation (the “Company”), in its Current Report on Form 8-K filed with the SEC on February 2, 2026 (the “February 8-K”), the Company entered into an entrusted investment agreement (the “Entrusted Investment Agreement”) with GOLD KING ARTHUR HOLDING LIMITED (“GKA”) and Song Wang (“Song”), under which the Company entrusted to GKA to manage an…

Results of Operations and Financial Condition On March 24, 2026, the Company issued a press release announcing its financial and operational results for the fiscal year ended December 31, 2025, and an investor webcast that occurred on March 24, 2026 to discuss such results and update shareholders on general corporate developments. The press release and the investor presentation are attached as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K (this “Form 8-K”) and are i…

Co-Chief Executive Officer — Jiawei Wang: Mr. Jiawei Wang was appointed as Co-Chief Executive Officer and entered into an employment agreement.

Entry into a Material Definitive Agreement Entry into Advisor Agreement On February 10, 2026, AIxCrypto Holdings, Inc. (the “Company”) entered into an advisor agreement (the “Advisor Agreement”), effective as of October 2, 2025, with Yueting (YT) Jia (“Advisor”). Pursuant to the Advisor Agreement, the Company has engaged Advisor to provide a range of consulting services to support the Company’s strategic goals, including to serve as Chief Advisor for the Company (the “Services”). The services…

Other Events On January 27, 2026, the Company entered into a non-binding letter of intent (“LOI”) with Aster Foundation, a Cayman Islands foundation company (“Aster”), under which the Company and Aster would use commercially reasonable efforts to collaborate on general business opportunities and to share such capabilities with proposed areas and scope of collaboration as agreed between the parties, which includes collaboration on efforts relating to the Sei blockchain infrastructure. Addition…

Entry into a Material Definitive Agreement Entry into a Consulting Agreement On January 28, 2026, AIxCrypto Holdings, Inc. (the “Company”) entered into a consulting services agreement (the “Consulting Agreement”), effective as of November 1, 2025, with FF Global Partners LLC (“Consultant”). Pursuant to the Consulting Agreement, the Company has engaged Consultant to provide a range of consulting services to support the Company’s strategic goals. The services to be provided by Consultant includ…

Changes in Registrant’s Certifying Accountant. On December 12, 2025, the Audit Committee of the Board of Directors of AIxCrypto Holdings, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”) terminated Macias Gini & O’Connell LLP (“MGO”) as the independent registered public accounting firm of the Company. During the Company’s two most recent fiscal years and the subsequent interim period through December 12, 2025, there were no disagreements with MGO on any…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Non-Compliance with Nasdaq Listing Rule 5635(b) On November 18, 2025, the Company received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it failed to comply with Nasdaq’s shareholder approval requirements set forth in Nasdaq Listing Rule 5635(b) (the “Rule”), which requires shareholder appro…

Director — Graydon Bensler and Braeden Lichti: Two directors resigned from the Board.

Co-Chief Executive Officer — Jiawei Wang: Mr. Jiawei Wang was promoted to Co-Chief Executive Officer.

Changes in Registrant’s Certifying Accountant. Resignation of Independent Registered Public Accounting Firm On October 1, 2025, WithumSmith+Brown, PC (“Withum”) notified the Audit Committee of the Board of Directors (the “Audit Committee”) of Qualigen Therapeutics, Inc. (the “Company”) that it had resigned as the Company’s independent registered public accounting firm, effective immediately. The Audit Committee accepted Withum’s resignation. Withum advised the Company in writing (the “Notice”…

Entry into a Material Definitive Agreement. Private Placement Offering On September 19, 2025, Qualigen Therapeutics, Inc., a Delaware corporation (the “Company”) entered into a Subscription Agreement (the “Subscription Agreement”) with certain investors (the “Suscribers”), including Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI)(the “Lead Investor”) pursuant to which the investors agreed to purchase $41,000,000 in cash (the “Offering”) of the Company’s common stock, par value $0.001…

Unregistered Sales of Equity Securities. The information under

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On September 4, 2025, Qualigen Therapeutics, Inc. (the “Company”) received a written decision (the “Decision Letter”) from the Nasdaq Hearings Panel (the “Panel”) in response to the Company’s August 19, 2025 update and request for a compliance determination with respect to the Panel’s July 24, 2025 decision, as amended. As previously disclosed, on July 24, 2025, the Panel granted the Company an…